Newcombe; Nicholas John
Patent Applications and Registrations
Patent applications and USPTO patent grants for Newcombe; Nicholas John.The latest application filed is for "2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators".
- Newcombe; Nicholas John - Cheshire GB
- Newcombe; Nicholas John - Macclesfield GB
- Newcombe, Nicholas John - Macclesfield Cheshire GB
| Patent | Date |
|---|---|
| 2-phenyl Substituted Imidazol [4,5b] Pyridine/pyrazine And Purine Derivatives As Glucokinase Modulators App 20110059941 - Caulkett; Peter William Rodney ; et al. | 2011-03-10 |
| Therapeutic Agents - 551 App 20090118332 - Butlin; Roger John ; et al. | 2009-05-07 |
| Heterobicyclic Compounds As Glucokinase Activators App 20090105263 - Caulkett; Peter William Rodney ; et al. | 2009-04-23 |
| Therapeutic Agents - 550 App 20090105305 - Butlin; Roger John ; et al. | 2009-04-23 |
| Pyrimidine compounds Grant 7,485,638 - Newcombe , et al. February 3, 2 | 2009-02-03 |
| Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity Grant 7,465,728 - Newcombe , et al. December 16, 2 | 2008-12-16 |
| Pyrimidine compounds Grant 7,446,105 - Newcombe , et al. November 4, 2 | 2008-11-04 |
| 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity Grant 7,442,697 - Newcombe , et al. October 28, 2 | 2008-10-28 |
| Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) Grant 7,342,020 - Barlaam , et al. March 11, 2 | 2008-03-11 |
| Novel fused triazolones and the uses thereof App 20070149560 - Ashwell; Susan ; et al. | 2007-06-28 |
| Metalloproteinase inhibitor compounds Grant 7,122,551 - Barlaam , et al. October 17, 2 | 2006-10-17 |
| 4-Imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity App 20060074096 - Newcombe; Nicholas John ; et al. | 2006-04-06 |
| Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation App 20060004033 - Breault; Gloria Anne ; et al. | 2006-01-05 |
| Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation Grant 6,969,714 - Breault , et al. November 29, 2 | 2005-11-29 |
| Pyrimidine compounds App 20050256311 - Newcombe, Nicholas John ; et al. | 2005-11-17 |
| 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors Grant 6,939,872 - Newcombe , et al. September 6, 2 | 2005-09-06 |
| Pyrimidine derivatives Grant 6,908,920 - Thomas , et al. June 21, 2 | 2005-06-21 |
| Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity App 20050131000 - Newcombe, Nicholas John ; et al. | 2005-06-16 |
| Pyrimidine compounds App 20050119291 - Newcombe, Nicholas John ; et al. | 2005-06-02 |
| 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors App 20040198757 - Newcombe, Nicholas John ; et al. | 2004-10-07 |
| Imidazolo-5-YL-2anilino-pyrimidines as agents for the inhibition of the cell proliffration App 20040014776 - Breault, Gloria Anne ; et al. | 2004-01-22 |
| Pyrimidine derivatives App 20030216406 - Thomas, Andrew Peter ; et al. | 2003-11-20 |
| Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents App 20030139419 - Barlaam, Bernard ; et al. | 2003-07-24 |
| Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp) App 20030100548 - Barlaam, Bernard Christophe ; et al. | 2003-05-29 |
| Heterocyclic compounds useful as pharmaceutical agents Grant 6,313,127 - Waterson , et al. November 6, 2 | 2001-11-06 |
| Substituted pyrimidine derivatives and their pharmaceutical use Grant 6,093,718 - Waterson , et al. July 25, 2 | 2000-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 